Todd M Pitts

7PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersSolid tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 13, 2026
Decitabine reverses innate immune gene suppression in rare melanomas.

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Jul 17, 2024
Endogenous retroviruses mediate transcriptional rewiring in response to oncogenic signaling in colorectal cancer.

Atma Ivancevic, David M Simpson, Olivia M Joyner

|Jun 13, 2024
A Phase II Study of Potentiation of Pembrolizumab with Binimetinib and Bevacizumab in Refractory Microsatellite-Stable Colorectal Cancer.

Robert W Lentz, Tyler J Friedrich, Patrick J Blatchford

|Apr 27, 2024
A Phase Ib Expansion Cohort Evaluating Aurora A Kinase Inhibitor Alisertib and Dual TORC1/2 Inhibitor Sapanisertib in Patients with Advanced Solid Tumors.

S Lindsey Davis, Wells A Messersmith, W Thomas Purcell

|Apr 10, 2024
Examination of Wnt signaling as a therapeutic target for pancreatic ductal adenocarcinoma (PDAC) using a pancreatic tumor organoid library (PTOL).

Hayley J Hawkins, Betelehem W Yacob, Monica E Brown

Pageof 2

Frequent Collaborators

4 joint publications

Stacey M Bagby

3 joint publications

Adrian T A Dominguez

3 joint publications

Wells A Messersmith

3 joint publications

Christopher H Lieu